MedPath

Effects of Social Gaze Training on Brain and Behavior in Fragile X Syndrome

Phase 1
Completed
Conditions
Intellectual Disability
Fragile X Syndrome
Registration Number
NCT02616796
Lead Sponsor
Stanford University
Brief Summary

The purpose of the study is to evaluate a 2-3 day treatment probe targeted to improving social gaze behavior in children with fragile X syndrome (FXS). The investigators will use the principles of Applied Behavior Analysis (ABA) to shape appropriate social skills. Importantly, the investigators propose to examine the effects of this treatment probe on brain and behavior.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
71
Inclusion Criteria
  1. Boys diagnosed with fragile X syndrome
  2. Boys with intellectual disability who do not have FXS or other known genetic disorder associated with intellectual disability
  3. Age 8 to 18 years inclusive
  4. Ability to travel to Stanford
  5. Vineland Adaptive Behavior Scales standard score between 50 and 75 points
Exclusion Criteria
  1. Sensory impairments, or any other serious medical or neurological condition that affects growth or development (e.g., seizure disorder, diabetes, congenital heart disease).
  2. Materials in body that would preclude an MRI scan (e.g., dental braces).

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Percentage of social gaze aversion recorded during the social challenge3 days
Total t-score on the Social Responsiveness Scale (SRS)4 weeks
Heart rate recorded during the social challenge3 days
Secondary Outcome Measures
NameTimeMethod
Verbal responses and pauses in conversation observed during the social challenge3 days
Fractional Amplitude of Low Frequency fluctuations (fALLF) measured in the insular cortex3 days

Trial Locations

Locations (1)

Stanford University School of Medicine

🇺🇸

Stanford, California, United States

Stanford University School of Medicine
🇺🇸Stanford, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.